Medical and Pharmaceutical Cancer remains Canada’s top killer as 2026 cases exceed 254,000 Age-standardized death rates are projected to decline overall Joseph MortonApril 17, 2026
AI and Autonomy Artificial intelligence reshapes cancer diagnosis from detection to prediction Developers have expanded AI applications into broader diagnostic tasks Joseph MortonApril 14, 2026
Health & Wellness Mayo Clinic study shows robotic tech improves early lung cancer diagnosis The system also integrates endobronchial ultrasound to examine nearby lymph nodes Joseph MortonApril 8, 2026
Medical and Pharmaceutical BriaCell transfers cancer immunotherapy asset to BriaPro in USD$1.18 million deal BriaCell originally licensed the technology from the University of Maryland Joseph MortonApril 2, 2026
Medical and Pharmaceutical Guardant Health gets oncology innovation accolade at Healthcare Asia Medtech Awards 2026 The company was recognized for its multi-cancer detection test Rowan DunneMarch 31, 2026
Medical and Pharmaceutical Enliven Therapeutics stock climbs on upgrades, sector validation from Merck acquisition Enliven Therapeutics is a clinical-stage biotech company focused on developing targeted cancer drugs Joseph MortonMarch 26, 2026
Medical and Pharmaceutical Immutep completely tanks after discontinuing lung cancer drug trial Shares dropped by 88% on Friday the 13th, leaving investors shook Rowan DunneMarch 16, 2026
Medical and Pharmaceutical Tango Therapeutics rallies after oncology drug collaboration with Erasca Researchers think combining both drugs could create stronger and longer-lasting tumor responses Joseph MortonMarch 5, 2026
Medical and Pharmaceutical Optellum breaks new ground with TGA approval for AI-powered lung nodule solution 'Radiological computer-assisted diagnostic software for lesions suspicious of cancer' is what the FDA calls it Rowan DunneMarch 5, 2026
Medical and Pharmaceutical Icahn researchers target lysosomes to reverse stem cell aging The research focused on hematopoietic stem cells, often called HSCs Joseph MortonFebruary 26, 2026